Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESSENCE-2: CyclASol in Dry Eye Disease
NCT04523129Phase 3Completed
- Sponsor
- Novaliq GmbH
- Start
- Dec 2020
- Primary completion
- Sep 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vevye in dry eye disease (DED), sponsored by Novaliq GmbH. Started Dec 2020; status: completed.
02
Drugs
vevye
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04523129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04523129.